<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-09-02">September 2, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">M</forename><surname>Reincke</surname></persName>
							<email>martin.reincke@med.uni-muenchen.de</email>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik und Poliklinik IV</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">U</forename><forename type="middle">D</forename><surname>Lichtenauer</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik und Poliklinik IV</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of General Internal Medicine, Endocrinology and Diabetology</orgName>
								<orgName type="institution">HELIOS Kliniken</orgName>
								<address>
									<settlement>Schwerin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Gerum</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik und Poliklinik IV</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Klinik und Poliklinik für Strahlentherapie und Radioonkologie</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Asbach</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik und Poliklinik IV</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Manolopoulou</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik und Poliklinik IV</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Tyne and Wear</orgName>
								<orgName type="institution">Immunodiagnostic Systems Ltd</orgName>
								<address>
									<settlement>Boldon</settlement>
									<country key="GB">U. K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">V</forename><surname>Fourkiotis</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Clinical Endocrinology</orgName>
								<orgName type="institution">Charité University Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Mitte</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Department of Gastroenterology and Endocrinology</orgName>
								<orgName type="institution">Philipp&apos;s University</orgName>
								<address>
									<settlement>Marburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Quinkler</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Clinical Endocrinology</orgName>
								<orgName type="institution">Charité University Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Mitte</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Endocrinology in Charlottenburg</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Bidlingmaier</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Endocrinology</orgName>
								<orgName type="department" key="dep2">Medizinische Klinik und Poliklinik IV</orgName>
								<orgName type="institution">Klinikum der Universität München</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Endocrinology, Medizinische Klinik und Poliklinik IV Klinikum</orgName>
								<orgName type="institution">Universität München Ziemssenstrasse</orgName>
								<address>
									<postCode>80336</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<idno type="ISSN">0018-5043</idno>
						<imprint>
							<date type="published" when="2016-09-02">September 2, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">6BD647E0E7CE0836F462E86086C1DA48</idno>
					<idno type="DOI">10.1055/s-0042-114037</idno>
					<note type="submission">received 02.03.2016 accepted 25.07.2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><formula xml:id="formula_0">• ▶ aldosterone • ▶ rennin • ▶ Conn's syndrome • ▶ hypertension • ▶ saliva • ▶ aldosterone producing adenoma</formula><p><s>The Clinical Value of Salivary Aldosterone in Diagnosis and Follow-Up of Primary Aldosteronism <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s>As aldosterone is a lipid soluble steroid hormone, it readily passes through the cell membrane into saliva by simple diffusion.</s><s>Salivary aldosterone concentrations are approximately 30 % lower compared to plasma aldosterone concentrations, however, the diffusion rate is independent of saliva production <ref type="bibr" target="#b12">[13]</ref> and salivary aldosterone levels correspond well with plasma aldosterone levels.</s><s>Samples can easily be obtained without special training, and are stable for several days at room temperature <ref type="bibr" target="#b13">[14]</ref>.</s><s>We have previously shown that when measuring salivary aldosterone concentrations and applying a cutoff value of 81 pg/ml, primary hyperaldosteronism was detected with a sensitivity of 77 % and a specificity of 82 % under experimental conditions <ref type="bibr" target="#b9">[10]</ref>.</s><s>In this study, aldosterone measurements from patients with primary hyperaldosteronism (PA) and hypertensive controls (HC) enrolled in the German Conn's Registry were prospectively per-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction ▼</head><p><s>Hyperaldosteronism can be detected in 5-13 % of hypertensive patients <ref type="bibr" target="#b0">[1]</ref> and is associated with severe morbidity <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref>.</s><s>Aldosterone excess is caused primarily by aldosterone producing unilateral adenomas (APA) and bilateral adrenal hyperplasia (BAH) <ref type="bibr" target="#b4">[5]</ref>.</s><s>Most commonly, the diagnosis is established by an elevated plasma aldosteronerenin-ratio (ARR) and a pathologic confir matory test such as the saline infusion test <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>Unilateral adrenalectomy is the treatment of choice for aldosterone producing adenomas, while treatment with mineralocorticoid antagonists is recommended in bilateral disease <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s>Repeated aldosterone measurements pre-and postoperatively and during follow-up visits are required for accurate monitoring of treatment effectiveness and outcome.</s><s>Salivary aldosterone sampling has been proposed as a simple, costeffective and reliable method for these purposes Primary aldosteronism (PA), the most common form of secondary hypertension, causes relevant morbidity.</s><s>The value of salivary measurements of aldosterone in clinical routine in PA so far has not been assessed.</s><s>First, we analyzed salivary and plasma aldosterone concentrations of 42 patients with PA and 37 hypertensive controls (HC) during a sodium infusion test prospectively.</s><s>Second, morning salivary and plasma aldosterone concentrations as well as diurnal saliva aldosterone profiles were analyzed in 115 patients treated for PA (46 adrenalectomy, 56 spironolactone, 13 eplerenone).</s><s>Salivary aldosterone was substantially elevated in PA patients compared to HC at baseline (106 ± 119 vs. 40 ± 21 ng/l, p = 0.01), and after 4-h sodium infusion test (60 ± 36 vs. 23 ± 14, p = 0.01).</s><s>Positive correlation between salivary and plasma aldosterone levels was evident, with exception of concentrations in or below the lower normal range.</s><s>Applying a salivary aldosterone cutoff of 51.2 ng/l, found by ROC curve analysis, rendered a sensitivity of 81 % and a specificity of 73 % for PA.</s><s>The diurnal rhythm of aldosterone was preserved in untreated PA patients, but concentrations were higher in the context of PA, and normalized after surgery (118 ± 57 vs. 31 ± 18 ng/l, p &lt; 0.01).</s><s>Taken together, salivary aldosterone measurements correlate with plasma levels, allowing simple and cost effective assessments of aldosterone secretion in an outpatient setting.</s><s>Nevertheless, as this method alone cannot replace other plasma parameters, and as aldosterone profiling would not alter diagnostic or treatment strategies, salivary aldosterone measurements in routine practice are of limited clinical value.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Endocrine Care</head><p><s>formed in parallel in saliva and plasma during a saline infusion test.</s><s>In addition, morning plasma aldosterone values taken at outpatient visits in our center were correlated with the patients' salivary aldosterone values taken at home, and the diurnal rhythm of aldosterone was assessed in the different cohorts.</s><s>The effectiveness of salivary aldosterone daily profiling to monitor treatment outcomes after surgery and under mineralcorticoidantagonist treatment was addressed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>▼</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and test conditions</head><p><s>The tertial referral centers LMU Munich and Charité Berlin had enrolled all patients in this study, approved by local ethic committees, by informed consent in the German Conn's Registry -Else Kröner-Fresenius-Hyperaldosteronismus-Registry.</s><s>PA was diagnosed in accordance with the cutoff established in our laboratory and the Endocrine Society Practice Guidelines aldosterone concentration (ARR &gt; 12 ng/l/μU/ml and aldosterone concentration &gt; 50 ng/l after saline infusion) <ref type="bibr" target="#b6">[7]</ref>.</s><s>Seventy-nine patients with suspected PA were assessed by a saline infusion test prospectively.</s><s>The diagnosis was confirmed in 42 and excluded in 37 patients.</s><s>These 37 patients served as a hypertensive control (HC) cohort (demographic data • ▶ Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>In addition, this test was performed again in 12 patients with persistent hypertension or elevated aldosterone-renin-ratios after adrenalectomy (demographic data • ▶ Table <ref type="table" target="#tab_3">2</ref>).</s></p><p><s>Furthermore, plasma and salivary aldosterone measurements in the morning as well as salivary aldosterone diurnal profiles were analyzed in 115 retrospective patients.</s><s>These patients had been diagnosed with primary hyperaldosteronism months to years earlier, and were included in the registry during follow-up.</s><s>The patients had been undergoing either adrenalectomy (ADX, n = 46) or mineralcocorticoid antagonist treatment in the case of BAH (spironolactone, n = 56, and eplerenone, n = 13; demographic data • ▶ Table <ref type="table" target="#tab_4">3</ref>).</s><s>Patients were instructed to sample saliva at the time points 8:00, 12:00, 16:00, 20:00 and 22:00 h at home.</s><s>All saliva samples were collected with the Salivette ® (Sarstedt, Nümbrecht, Germany) device.</s><s>Patients were asked not to eat or brush their teeth within 30 min before chewing the swab, and not to touch the swap.</s><s>Besides these instructions, salivary samples were collected on an outpatient basis without further standardization.</s><s>Samples were kept at 4 °C until transport to the hospital.</s><s>Salivettes subsequently were centrifuged for 10 min at 2 000 rpm at 20 °C, and the flow-through collected for further analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sodium infusion test</head><p><s>The test was performed under standardized test conditions if primary aldosteronism was suspected as outlined in the Clinical Practice Guidelines <ref type="bibr" target="#b6">[7]</ref>.</s><s>Potassium was supplemented when the potassium concentration was below 3.5 mmol/l and interfering antihypertensive medication was changed to non-dihydropyridin calcium channel blockers and alpha-blockers whenever possible.</s><s>Patient were fasting and seated for 10 min, before 2 liters of saline solution (0.9 % NaCl) were infused over 4 h under blood pressure monitoring starting at 8:00 AM in the morning.</s><s>At baseline and after 4 h, plasma was drawn for measurements of aldosterone, renin, potassium, sodium, and creatinine.</s><s>Salivary aldosterone samples were taken simultaneously.</s><s>Contraindications were heart failure NYHA III-IV, a myocardial infarction within 3 months prior to testing, and hypertensive blood pressure readings (&gt; 180 mmHg systolic, or &gt; 100 mmHg diastolic).</s><s>Suppression of plasma aldosterone below 50 ng/l excluded a clinically relevant primary hyperaldosteronism.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Aldosterone measurements</head><p><s>Salivary aldosterone was measured using a time-resolved fluorescence immunoassay (TR-FIA) as described previously <ref type="bibr" target="#b9">[10]</ref>.</s></p><p><s>Briefly, calibrators, controls and samples (50 μl) were pipetted in duplicates, along with 100 μl of aldosterone</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Quantitative values were depicted as statistical average and standard deviation.</s><s>Statistical comparisons were performed using the Wilcoxon-Mann-Whitney test for 2 unmatched groups.</s><s>More than 2 unmatched groups were compared using the nonparametric Kruskal-Wallis test.</s><s>Linear dependencies between metric variables were quantified by applying Pearsons's correlations coefficient.</s><s>2-sided p-values &lt; 0.05 were considered statistically significant.</s><s>Due to the explorative nature of this project, a normalization of potential confounders was not performed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>▼</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Salivary aldosterone at time of diagnosis and during sodium infusion</head><p><s>Salivary aldosterone concentrations at 8:00 AM were significantly lower compared to plasma aldosterone concentrations and they differed significantly between patients with primary aldosteronism (PA n = 42), hypertensive controls (HC, n = 37), and after surgery (n = 12) ( • ▶ Table <ref type="table" target="#tab_0">1</ref> and • ▶ Fig. <ref type="figure" target="#fig_0">1a</ref>).</s><s>A significant correlation between salivary and plasma aldosterone levels was observed (PA r = 0.51, p &lt; 0.01, • ▶ Fig. <ref type="figure" target="#fig_0">1b</ref>; HC r = 0.335, p = 0.04; • ▶ Table <ref type="table" target="#tab_0">1</ref>).</s><s>Applying a Receiver Operating Characteristic (ROC) curve analysis with a 95 % confidence interval for 8:00 AM salivary concentrations of PA vs. HC patients, an area under the curve (AUC) of 0.85 (0.772-0.937; std.</s><s>error 0.04; p &lt; 0.001) with a sensitivity of 81.0 % (65.9-91.4) and a specificity of 73.0 % (55.9-86.2) could be achieved at an aldosterone concentration of 51.15 ng/l ( • ▶ Fig. <ref type="figure" target="#fig_0">1c</ref>).</s></p><p><s>Aldosterone concentrations after the saline infusion test differed significantly between PA and HC patients (p &lt; 0.01), as expected, in both, saliva and plasma measurements.</s><s>In contrast, salivary and plasma aldosterone concentrations in patients after adrenalectomy and HC patients were similar before (p = 0.75) and after (p = 0.27) saline infusion ( • ▶ Table <ref type="table" target="#tab_0">1</ref> and • ▶ Fig. <ref type="figure" target="#fig_0">1a</ref>).</s></p><p><s>Salivary and plasma aldosterone concentrations at 8:00 AM were analyzed in patients after successful adrenalectomy for PA and in BAH patients receiving spironolactone or eplerenone.</s><s>Saliva and plasma aldosterone differed significantly between all groups while levels correlated mostly positively within each subgroup (newly diagnosed PA r = 0.719, p &lt; 0.01; APA patients after surgery r = 0.285, p = 0.058; spironolactone treated PA patients r = 0.622, p &lt; 0.01; eplerenone treated PA patients r = 0.817, p &lt; 0.01; • ▶ Table <ref type="table" target="#tab_4">3</ref>).</s></p><p><s>Interestingly, subgroup analysis revealed that plasma aldosterone values at 8:00 AM were significantly higher in APA patients compared to BAH patients (429 ± 395 vs. 184 ± 73 ng/l, p = 0.013).</s></p><p><s>Although this tendency was also seen for salivary aldosterone, a statistical significance was not reached (APA n = 29, 120 ± 140 ng/l vs. BAH n = 9, 76 ± 25 ng/l, p = 0.36; data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Salivary aldosterone profiling</head><p><s>In untreated patients with PA, higher aldosterone levels (PA n = 42; 100 ± 73 ng/l vs. APA patients after successful adrenalectomy n = 48; 59 ± 43 ng/l, p &lt; 0.05) and a steeper decline within 24 h was observed ( • ▶ Fig. <ref type="figure" target="#fig_0">1d</ref>).</s><s>In contrast, aldosterone curves of spironolactone treated BAH patients (n = 56, 11 spironolactone alone, 45 combinatory therapy; average dose: 60 ± 41 (13-200) mg/day) and patients with untreated PA, with the exception of 22:00 (p = 0.01), were similar ( • ▶ Table <ref type="table" target="#tab_4">3</ref> and • ▶ Fig. <ref type="figure" target="#fig_0">1d</ref>).</s><s>Salivary aldosterone concentrations also tended to be higher in eplerone treated patients (n = 13, 7 eplerenone alone, 6 combinatory therapy, average dose 74 ± 45 (13-150) mg/day) compared to untreated patients, and statistical significance was reached at 16:00 (p = 0.04) and 22:00 h (p &lt; 0.01).</s></p><p><s>In 12 patients, who remained hypertensive or still had an elevated aldosterone-renin-ratio after surgery, paired pre-and postoperative salivary aldosterone profiles were available ( • ▶ Table <ref type="table" target="#tab_3">2</ref>).</s><s>Again, a maintained diurnal rhythm on a much higher level was observed for patients before surgery.</s><s>Both, salivary and plasma aldosterone concentrations after surgery were much lower at 8:00 AM in the morning and at all other time points studied with salivary profiling (8:00 AM salivary:</s></p><p><s>118 ± 57 ng/l before and 31 ± 18 ng/l after surgery, p &lt; 0.01; • ▶ Fig. <ref type="figure" target="#fig_0">1e</ref>; plasma 345 ± 204 ng/l before and 73 ± 43 ng/l after surgery, p &lt; 0.01; paired values • ▶ Fig. <ref type="figure" target="#fig_0">1f</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Endocrine Care</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>▼</head><p><s>A systematic screening for clinically relevant hyperaldosteronism warrants repeated aldosterone measurements, both, for establishing the diagnosis and reliable follow-up.</s><s>Determination of aldosterone levels based on a fluorescence-immunoassay in saliva has been proposed as a simple and cost effective alternative in previous studies <ref type="bibr" target="#b9">[10]</ref>.</s><s>In this study, the suitability and validity of this so far experimental method was assessed in a large patient cohort under routine clinical conditions.</s><s>In some, but not all of our samples, a close correlation between salivary and plasma aldosterone levels could be found.</s><s>At 8:00 AM a sensitivity of 81 % and a specificity of 73 % for detecting hyperaldosteronism utilizing saliva samples could be achieved, in agreement to what we have previously published, however, at a much lower cutoff level of 51.2 ng/l, which is most likely attributed to the different cohorts studied.</s><s>However, although sensitivity and specificity are in the range reported for other diagnostic tools, this method alone, similar to plasma testing alone, is not suitable as a screening method to reliably detect patients with pathologically elevated aldosterone concentrations.</s></p><p><s>In addition, as saliva contains the free, non-protein bound hormone, salivary aldosterone concentrations are generally much lower compared to plasma levels.</s><s>Differences between the patient cohorts studied with values in the lower normal range, for example, after the saline infusion test, became minimal and did not reach statistical significance.</s><s>This lack of discriminatory power at lower levels, however, is not deemed clinically relevant in most cases.</s></p><p><s>While plasma aldosterone levels were significantly higher in unilateral disease compared to bilateral disease, these differences could not be seen with salivary aldosterone measurements, most likely due to the larger scatter of values in the APA group.</s></p><p><s>Salivary hormone assays allow simple multiple non-invasive aldosterone measurements within an outpatient setting.</s><s>Herein, the circardian rhythm of salivary aldosterone was assessed on an outpatient basis on a large cohort for the first time, and the results are similar to plasma measurements in primary hyperaldosteronism published earlier <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>.</s><s>The profiles mirror well the typical diurnal rhythm of plasma aldosterone, with the highest concentrations in the morning hours, which gradually decline throughout the day.</s><s>Interestingly, a disruption of the diurnal rhythm, for example, similar to patients suffering from hypercortisolism, could not be observed in PA.</s><s>We can only speculate that the differences in aldosterone concentrations between hypertensive controls and APA patients were not severe enough to completely suppress the circardian rhythm.</s><s>However, the decline of aldosterone concentrations throughout the day is much less pronounced in the APA group, suggesting that the autonomous aldosterone secretion in this group might have precluded a further decline.</s><s>However, aldosterone levels were significantly higher compared to aldosterone profiles in hypertensive controls, and surgical intervention resulted in a normalization of the salivary aldosterone profile.</s><s>Interestingly, this was also seen in the majority of patients, who remained hypertensive or with elevated aldosterone-renin-ratios after surgery.</s><s>This emphasizes the difficulty to adequately define a successful treatment.</s><s>Plasma and salivary aldosterone measurements did not always correlate significantly in these subgroups, but there was a general trend for higher salivary aldosterone concentrations in patients under aldosterone antagonist treatment compared to untreated patients.</s><s>Salivary aldosterone concentrations were highest in the eplerenone treated group.</s><s>Several reason might explain this difference between groups, such as a per se higher disease activity in eplerenone treated patients, lower medical adherence in spironolactone treated patients, or differences in The remarkable increase of aldosterone concentrations after 12:00 and 20:00 h might reflect the pharmacological action of eplerenone, which was given twice daily.</s><s>However, statistical significance was not reached for several times points, most likely due to the small cohort size of the subpopulations.</s><s>Therefore, although these different aldosterone profiles are interesting, clearly the data does not allow to test aldosterone antagonist treatment efficiency or dose titration by salivary aldosterone sampling.</s></p><p><s>Taken together, aldosterone profiling with multiple saliva measurements a day is a simple, non-invasive method.</s><s>The lack of standardization, the lack of a closer correlation with plasma aldosterone measurements, and lack of relevant additional information from daily profiles, together with the need for further laboratory parameters for proper clinical testing and follow-up, substantiates, that this method is of little clinical value in its current form.</s></p><p><s>Strength and limitations of the study: A strength of this study is that comparable plasma and salivary measurements were taken on a large patient cohort under standardized conditions set by the German Conn Registry.</s><s>Another, that parts of the data were collected prospectively, allowing accurate sensitivity and specificity calculations.</s><s>In addition, paired aldosterone measurements pre-and postoperatively in 12 patients allow to demonstrate treatment efficacy, even when hyperkalemia or hypertension persists.</s><s>The results are limited by the fact that the number of patients is still not large enough to reliably discriminate aldosterone concentration differences at lower concentrations and in different subgroups.</s><s>Limitations of the study include the sensitivity of the aldosterone assays, making reproducibility and agreement at low aldosterone concentrations questionable.</s><s>Such limitations have been reported for plasma aldosterone concentrations before <ref type="bibr" target="#b16">[17]</ref>, but might be even more important for salivary aldosterone concentrations, which are even lower than those found in plasma.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Aldosterone concentrations in saliva and plasma of prospective cohort at baseline and after saline infusion depicted as a comparative bar graph a. Correlation of plasma and salivary values as a linear regression plot exemplarily depicted for untreated patients with hyperaldosteronism b.</s><s>ROC curve for identifying patients with primary aldosteronism with salivary aldosterone measurements at 8:00 AM c. Mean salivary aldosterone concentrations of the different subgroups shown at different time points throughout the day in a comparative dot plot d.</s><s>Mean salivary aldosterone concentrations pre-and postoperatively shown at different time points throughout the day in a comparative dot plot e.</s><s>Individual changes in salivary aldosterone concentrations before and after surgery f.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Demographic data of the prospective cohort and aldosterone concentrations in saliva and plasma of prospective cohort at baseline and after saline infusion (arithmetic mean, standard deviation, median), and correlation of plasma and salivary values.</s></p></div></figDesc><table><row><cell>Prospective</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>cohort Primary aldosteron- ism Hyperten- sive controls After surgery Kruskal- Wallis test</head><label></label><figDesc></figDesc><table><row><cell>Number of patients</cell><cell>42</cell><cell>37</cell><cell>12</cell><cell></cell></row><row><cell>Sex (male, female)</cell><cell>31, 11</cell><cell>14, 23</cell><cell>9, 3</cell><cell></cell></row><row><cell>Age (years)</cell><cell>53 ± 10</cell><cell>53 ± 13</cell><cell>61 ± 11</cell><cell></cell></row><row><cell>Height (cm)</cell><cell>175 ± 8</cell><cell>169 ± 8</cell><cell></cell><cell></cell></row><row><cell>Weight (kg)</cell><cell>87 ± 19</cell><cell>79 ± 15</cell><cell></cell><cell></cell></row><row><cell>Number of antihypertensives</cell><cell>3 ± 2</cell><cell>2.5 ± 2</cell><cell>5/12 no antihypertensives</cell><cell></cell></row><row><cell>Systolic blood pressure (mmHg)</cell><cell>164 ± 28</cell><cell>162 ± 27</cell><cell>150 ± 17</cell><cell></cell></row><row><cell>Diastolic blood pressure (mmHg)</cell><cell>99 ± 15</cell><cell>97 ± 17</cell><cell>93 ± 11</cell><cell></cell></row><row><cell>Serum potassium (mmol/l)</cell><cell>3.1 ± 0.5</cell><cell>3.8 ± 0.2</cell><cell>4.1 ± 0.2</cell><cell></cell></row><row><cell>Hypokalemic patients ( %)</cell><cell>79 (33/42)</cell><cell>16 (6/37)</cell><cell></cell><cell></cell></row><row><cell>Aldosterone renin ratio</cell><cell>109 ± 159</cell><cell>30 ± 36</cell><cell></cell><cell></cell></row><row><cell>Unilateral disease ( %)</cell><cell>66 (28/42)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Plasma aldosterone concentration at baseline (ng/l)</cell><cell>288 ± 180, 227</cell><cell>103 ± 51, 95</cell><cell>71 ± 33, 72</cell><cell>p &lt; 0.01</cell></row><row><cell>Salivary aldosterone concentration at baseline (ng/l)</cell><cell>106 ± 119, 74</cell><cell>40 ± 21, 41</cell><cell>65 ± 108, 36</cell><cell>p &lt; 0.01</cell></row><row><cell></cell><cell></cell><cell>p to PA &lt; 0.01</cell><cell>p to HC = 0.75</cell><cell></cell></row><row><cell>Correlation coefficient (r) and p-value of correlation at baseline</cell><cell>0.51, &lt; 0.01</cell><cell>0.335, 0.04</cell><cell>− 0.38, 0.90</cell><cell></cell></row><row><cell>Plasma aldosterone concentration after sodium infusion (ng/l)</cell><cell>181 ± 141, 115</cell><cell>35 ± 1, 35</cell><cell>37 ± 3, 35</cell><cell>p &lt; 0.001</cell></row><row><cell></cell><cell></cell><cell>p to PA &lt; 0.01</cell><cell>p to HC n.s.</cell><cell></cell></row><row><cell>Salivary aldosterone concentration after sodium infusion (ng/l)</cell><cell>60 ± 36, 51</cell><cell>23 ± 14, 20</cell><cell>41 ± 50, 25</cell><cell>p &lt; 0.001</cell></row><row><cell></cell><cell></cell><cell>p to PA &lt; 0.01</cell><cell>p to HC = 0.27</cell><cell></cell></row></table><note><p><s>Correlation coefficient (r) and p-value of correlation after saline infusion 0.6, &lt; 0.001 − 0.075, 0.66 0.4, 0.188 r = Pearsons correlation coefficient; p = significance level; n.s.:Not significantEndocrine Care</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc><div><p><s>Demographic data, aldosterone concentrations in saliva at different time points for daily profiling, and morning plasma aldosterone levels for comparison (arithmetic average, standard deviation) before and after surgery in paired samples.</s></p></div></figDesc><table><row><cell></cell><cell cols="3">Paired aldosterone profiles</cell></row><row><cell></cell><cell>Primary</cell><cell>After</cell><cell>Wilcoxon</cell></row><row><cell></cell><cell>aldosteronism</cell><cell>surgery</cell><cell>test p</cell></row><row><cell>Number of patients</cell><cell>12</cell><cell></cell><cell></cell></row><row><cell>Sex (male, female)</cell><cell>7, 5</cell><cell></cell><cell></cell></row><row><cell>Number of antihypertensives</cell><cell>2 ± 2</cell><cell>0.9 ± 1</cell><cell></cell></row><row><cell>Systolic blood pressure (mmHg)</cell><cell>154 ± 21</cell><cell cols="2">138 ± 18 0.046</cell></row><row><cell>Diastolic blood pressure (mmHg)</cell><cell>92 ± 13</cell><cell>88 ± 16</cell><cell>0.83</cell></row><row><cell>Serum potassium (mmol/l)</cell><cell>3.3 ± 0.6</cell><cell>4.4 ± 0.4</cell><cell></cell></row><row><cell>Aldosterone Renin Ratio</cell><cell>182 ± 218</cell><cell>7 ± 9</cell><cell>&lt; 0.01</cell></row><row><cell>Plasma aldosterone (ng/l)</cell><cell>357 ± 209</cell><cell>76 ± 43</cell><cell>&lt; 0.01</cell></row><row><cell>Salivary aldosterone 8:00 h (ng/l)</cell><cell>118 ± 57</cell><cell>31 ± 18</cell><cell>0.01</cell></row><row><cell cols="2">Salivary aldosterone 12:00 h (ng/l) 108 ± 66</cell><cell>31 ± 29</cell><cell>&lt; 0.01</cell></row><row><cell cols="2">salivary aldosterone 16:00 h (ng/l) 86 ± 61</cell><cell>33 ± 41</cell><cell>&lt; 0.01</cell></row><row><cell cols="2">Salivary aldosterone 20:00 h (ng/l) 77 ± 37</cell><cell>21 ± 14</cell><cell>&lt; 0.01</cell></row><row><cell cols="2">Salivary aldosterone 22:00 h (ng/l) 70 ± 36</cell><cell>20 ± 12</cell><cell>&lt; 0.01</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3</head><label>3</label><figDesc><div><p><s>Demographic data of retrospective cohort.</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Retrospective cohort</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Primary</cell><cell>After</cell><cell>Spironolactone</cell><cell>Eplerenone</cell><cell>Kruskal-Wallis</cell></row><row><cell></cell><cell>aldosteronism</cell><cell>surgery</cell><cell></cell><cell></cell><cell>test</cell></row><row><cell>Number of patients</cell><cell>42</cell><cell>46</cell><cell>56</cell><cell>13</cell><cell></cell></row><row><cell>Sex (male, female)</cell><cell>30, 12</cell><cell>21, 27</cell><cell>36, 20</cell><cell>10, 0</cell><cell></cell></row><row><cell>Age (years)</cell><cell>51 ± 10</cell><cell>55 ± 11</cell><cell>66.1 ± 8</cell><cell>60 ± 13</cell><cell></cell></row><row><cell>Number of antihypertensives</cell><cell>2 ± 1</cell><cell>1 ± 1</cell><cell cols="2">11 spironolactone alone 7 eplerenone alone</cell><cell></cell></row><row><cell>Dose (mg/d)</cell><cell></cell><cell></cell><cell>60 ± 42</cell><cell>74 ± 45</cell><cell></cell></row><row><cell>Systolic blood pressure (mmHg)</cell><cell>157 ( ± 25)</cell><cell>136 ( ± 20)</cell><cell>139 ± 19</cell><cell>148 ± 19</cell><cell></cell></row><row><cell>Diastolic blood pressure (mmHg)</cell><cell>96 ± 14</cell><cell>85 ± 12</cell><cell>81 ± 12</cell><cell>86 ± 10</cell><cell></cell></row><row><cell>Serum potassium (mmol/l)</cell><cell>3.3 ± 0.5</cell><cell>4.1 ± 0.3</cell><cell>4.2 ± 0.3</cell><cell>3.9 ± 0.3</cell><cell></cell></row><row><cell>Plasma aldosterone 8:00 h (ng/l)</cell><cell>363 ± 356</cell><cell>102 ± 108</cell><cell>327 ± 263</cell><cell>471 ± 344</cell><cell>&lt; 0.01</cell></row><row><cell>Salivary aldosterone 8:00 h (ng/l)</cell><cell>100 ± 73</cell><cell>59 ± 43</cell><cell>113 ± 63</cell><cell>155 ± 126</cell><cell>&lt; 0.01</cell></row><row><cell>p-Value to untreated primary aldosteronism 8:00 h</cell><cell></cell><cell></cell><cell>0.19</cell><cell>0.26</cell><cell></cell></row><row><cell>Correlation coefficient (r) and p-value of correlation</cell><cell>0.719, &lt; 0.01</cell><cell cols="2">0.285, 0.058 0.622, &lt; 0.01</cell><cell>0.817, &lt; 0.01</cell><cell></cell></row><row><cell>Salivary aldosterone 12:00 h (ng/l)</cell><cell>81 ± 60</cell><cell>59 ± 68</cell><cell>89 ± 48</cell><cell>139 ± 119</cell><cell>&lt; 0.01</cell></row><row><cell>p-Value to untreated primary aldosteronism 12:00 h</cell><cell></cell><cell></cell><cell>0.26</cell><cell>0.09</cell><cell></cell></row><row><cell>Salivary aldosterone 16:00 h (ng/l)</cell><cell>81 ± 94</cell><cell>52 ± 60</cell><cell>85 ± 81</cell><cell>140 ± 129</cell><cell>&lt; 0.01</cell></row><row><cell>p-Value to untreated primary aldosteronism 12:00 h</cell><cell></cell><cell></cell><cell>0.12</cell><cell>0.04</cell><cell></cell></row><row><cell>Salivary aldosterone 20:00 h (ng/l)</cell><cell>61 ± 43</cell><cell>44 ± 50</cell><cell>85 ± 101</cell><cell>78 ± 45</cell><cell>&lt; 0.01</cell></row><row><cell>p-Value to untreated primary aldosteronism 20:00 h</cell><cell></cell><cell></cell><cell>0.37</cell><cell>0.17</cell><cell></cell></row><row><cell>Salivary aldosterone 22:00 h (ng/l)</cell><cell>50 ± 46</cell><cell>43 ± 46</cell><cell>74 ± 54</cell><cell>105 ± 65</cell><cell>&lt; 0.01</cell></row><row><cell>p-Value to untreated primary aldosteronism 22:00 h</cell><cell></cell><cell></cell><cell>&lt; 0.01</cell><cell>&lt; 0.01</cell><cell></cell></row></table><note><p><s>Aldosterone concentrations in saliva at different time points for daily profiling and morning plasma aldosterone levels for comparison (arithmetic mean, standard deviation) Aldosterone concentrations in saliva at different time points for daily profiling and morning plasma aldosterone levels for comparison (arithmetic mean, standard deviation) Correlation of plasma and salivary values: r = Pearsons correlation coefficient; p = significance level Endocrine Care pharmacokinetic profile or mineralocorticoid receptor affinity.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements ▼</head><p><s>This work was funded by a grant of the Else Kröner-Fresenius Stiftung in support of the German Conn's Registry-Else Kröner-Fresenius-Hyperaldosteronism Registry (2013_A182).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>▼</head><p><s>The authors declare no conflict of interest.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hannemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bidlingmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Friedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manolopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spyroglou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Volzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beuschlein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Seissler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rettig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Felix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Biffar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Doring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wallaschofski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reincke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="7" to="15" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism</title>
		<author>
			<persName><forename type="first">P</forename><surname>Milliez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Girerd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Plouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Blacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Safar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Mourad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1243" to="1248" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Comorbidities in primary aldosteronism</title>
		<author>
			<persName><forename type="first">M</forename><surname>Quinkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Born-Frontsberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Fourkiotis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="429" to="434" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Conn&apos;s Registry-Else Kroner-Fresenius-Hyperaldosteronism R. Observational study mortality in treated primary aldosteronism: the German Conn&apos;s registry</title>
		<author>
			<persName><forename type="first">M</forename><surname>Reincke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gerum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Merkle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pallauf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Quinkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hanslik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hahner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Allolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Holle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beuschlein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bidlingmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Endres</forename><forename type="middle">S</forename><surname>German</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="618" to="624" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Zennaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fernandes-Rosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boulkroun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Jeunemaitre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="947" to="952" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">Italian Society of H. Clinical management of primary aldosteronism: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA)</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Dalla</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
			<publisher>High Blood Press Cardiovasc Prev</publisher>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="71" to="75" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Endocrine S. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Funder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fardella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Gomez-Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mantero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stowasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Young</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Montori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="3266" to="3281" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Primary hyperaldosteronism: boundaries of diagnostics and therapy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Riester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reincke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beuschlein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dtsch Med Wochenschr</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="1982" to="1984" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Treatment of primary aldosteronism</title>
		<author>
			<persName><forename type="first">M</forename><surname>Quinkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Stewart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Pract Res Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="923" to="932" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Salivary aldosterone as a diagnostic aid in primary aldosteronism</title>
		<author>
			<persName><forename type="first">J</forename><surname>Manolopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gerum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mulatero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rossignol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Plouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reincke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bidlingmaier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="400" to="405" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Saliva as a medium for aldosterone measurement in repeated sampling studies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Manolopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mulatero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Maser-Gluth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rossignol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spyroglou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Vakrilova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Petersenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Zwermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Plouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reincke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bidlingmaier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Steroids</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="853" to="858" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Development and application of a direct radioimmunoassay for aldosterone in saliva</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Atherden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Corrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Al-Dujaili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Edwards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Steroids</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="845" to="855" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Steroid analysis in saliva: an overview</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Lewis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Biochem Rev</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="139" to="146" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Human saliva as a diagnostic specimen</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Hofman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="1621S" to="1625S" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Kem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Weinberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gomez-Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Furuyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Nugent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="2272" to="2277" />
			<date type="published" when="1973">1973</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism</title>
		<author>
			<persName><forename type="first">T</forename><surname>Sonoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Taura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kanamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yasoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Arai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Connect</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="173" to="179" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps</title>
		<author>
			<persName><forename type="first">C</forename><surname>Schirpenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Seiler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Maser-Gluth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Beuschlein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reincke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bidlingmaier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1749" to="1755" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
